Professional Documents
Culture Documents
Aroosa Qamar Pharmacology
Aroosa Qamar Pharmacology
Aroosa Qamar Pharmacology
● Pharmacotherapy, in
combination with behavioral
● Despite alcohol and cannabis
interventions, has the potential
being the most commonly used
to increase the likelihood of
substances during adolescence,
successful treatment for youth
only three medications have
struggling with SUD
been tested among this
● There are no Food and Drug demographic, and only two
have warranted further study
Administration (FDA)-
● naltrexone for alcohol
approved medications for
● N-acetylcysteine for cannabis
adolescent SUD, other than
use disorder).
buprenorphine, which has
been approved down to 16
years of age for opioid use
disorder.
Continue………….
● Although less common in ● In addition, despite the recent
adolescents and young adults, marked increases in electronic
the most promising nicotine delivery systems (i.e.,
pharmacological findings for vaping) among youth,
this age group are for opioid treatment strategies are still in
(buprenorphine) and tobacco their infancy and no
(bupropion and varenicline) recommendation exists for how
use disorders. to promote cessation for youth
vaping.
Thank You